Clinical Trial Update: SPEECH as Biomarker for Emotion, Movement and cOgnition in Parkinson's Disease [NA]

View source ↗

Summary

SPEECH as Biomarker for Emotion, Movement and Cognition in Parkinson's Disease is a trial evaluating speech-based biomarkers and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Parkinson Disease | NA | Status: RECRUITING